BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27000947)

  • 1. AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model.
    Cochez PM; Michiels C; Hendrickx E; Van Belle AB; Lemaire MM; Dauguet N; Warnier G; de Heusch M; Togbe D; Ryffel B; Coulie PG; Renauld JC; Dumoutier L
    Eur J Immunol; 2016 Jun; 46(6):1449-59. PubMed ID: 27000947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
    Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
    J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
    Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
    Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
    Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
    J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.
    Raifer H; Mahiny AJ; Bollig N; Petermann F; Hellhund A; Kellner K; Guralnik A; Reinhard K; Bothur E; Huber M; Bauer S; Löhning M; Kiss EA; Ganal SC; Diefenbach A; Korn T; Lohoff M
    Eur J Immunol; 2012 Dec; 42(12):3189-201. PubMed ID: 22961652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ-independent pathway.
    Yokosawa M; Kondo Y; Tahara M; Iizuka-Koga M; Segawa S; Kaneko S; Tsuboi H; Yoh K; Takahashi S; Matsumoto I; Sumida T
    Clin Exp Immunol; 2017 Apr; 188(1):22-35. PubMed ID: 27936495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.
    Martin B; Hirota K; Cua DJ; Stockinger B; Veldhoen M
    Immunity; 2009 Aug; 31(2):321-30. PubMed ID: 19682928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.
    Cibrian D; Saiz ML; de la Fuente H; Sánchez-Díaz R; Moreno-Gonzalo O; Jorge I; Ferrarini A; Vázquez J; Punzón C; Fresno M; Vicente-Manzanares M; Daudén E; Fernández-Salguero PM; Martín P; Sánchez-Madrid F
    Nat Immunol; 2016 Aug; 17(8):985-96. PubMed ID: 27376471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
    Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
    J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
    Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
    Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.
    Qiu J; Guo X; Chen ZM; He L; Sonnenberg GF; Artis D; Fu YX; Zhou L
    Immunity; 2013 Aug; 39(2):386-99. PubMed ID: 23954130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aryl hydrocarbon receptor: differential contribution to T helper 17 and T cytotoxic 17 cell development.
    Hayes MD; Ovcinnikovs V; Smith AG; Kimber I; Dearman RJ
    PLoS One; 2014; 9(9):e106955. PubMed ID: 25203682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of CD18 promotes expansion of inflammatory γδ T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.
    Gatzka M; Hainzl A; Peters T; Singh K; Tasdogan A; Wlaschek M; Scharffetter-Kochanek K
    J Immunol; 2013 Dec; 191(11):5477-88. PubMed ID: 24190659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis.
    Mabuchi T; Takekoshi T; Hwang ST
    J Immunol; 2011 Nov; 187(10):5026-31. PubMed ID: 21984702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.
    Itoh T; Hatano R; Komiya E; Otsuka H; Narita Y; Aune TM; Dang NH; Matsuoka S; Naito H; Tominaga M; Takamori K; Morimoto C; Ohnuma K
    J Invest Dermatol; 2019 Apr; 139(4):878-889. PubMed ID: 30423328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
    Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
    J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
    Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
    Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.